292 related articles for article (PubMed ID: 25125975)
1. Serum cytokine profiling and enrichment analysis reveal the involvement of immunological and inflammatory pathways in stable patients with chronic obstructive pulmonary disease.
Bade G; Khan MA; Srivastava AK; Khare P; Solaiappan KK; Guleria R; Palaniyar N; Talwar A
Int J Chron Obstruct Pulmon Dis; 2014; 9():759-73. PubMed ID: 25125975
[TBL] [Abstract][Full Text] [Related]
2. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
3. Serum IL-1β and IL-17 levels in patients with COPD: associations with clinical parameters.
Zou Y; Chen X; Liu J; Zhou DB; Kuang X; Xiao J; Yu Q; Lu X; Li W; Xie B; Chen Q
Int J Chron Obstruct Pulmon Dis; 2017; 12():1247-1254. PubMed ID: 28490868
[TBL] [Abstract][Full Text] [Related]
4. Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients.
Wu Y; Shen Y; Zhang J; Wan C; Wang T; Xu D; Yang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2015; 10():2405-12. PubMed ID: 26609227
[TBL] [Abstract][Full Text] [Related]
5. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.
de Llano LP; Cosío BG; Iglesias A; de Las Cuevas N; Soler-Cataluña JJ; Izquierdo JL; López-Campos JL; Calero C; Plaza V; Miravitlles M; Torrego A; Martinez-Moragon E; Soriano JB; Viña AL; Bobolea I
Int J Chron Obstruct Pulmon Dis; 2018; 13():591-601. PubMed ID: 29483774
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 and interleukin-8 blood levels' poor association with the severity and clinical profile of ex-smokers with COPD.
de Moraes MR; da Costa AC; Corrêa Kde S; Junqueira-Kipnis AP; Rabahi MF
Int J Chron Obstruct Pulmon Dis; 2014; 9():735-43. PubMed ID: 25114519
[TBL] [Abstract][Full Text] [Related]
7. Elevated plasma levels of pigment epithelium-derived factor correlated with inflammation and lung function in COPD patients.
Li X; Wang T; Yang T; Shen Y; An J; Liu L; Dong J; Guo L; Li D; Zhang X; Chen L; Xu D; Wen F
Int J Chron Obstruct Pulmon Dis; 2015; 10():587-94. PubMed ID: 25844034
[TBL] [Abstract][Full Text] [Related]
8. Eosinophil and T cell markers predict functional decline in COPD patients.
D'Armiento JM; Scharf SM; Roth MD; Connett JE; Ghio A; Sternberg D; Goldin JG; Louis TA; Mao JT; O'Connor GT; Ramsdell JW; Ries AL; Schluger NW; Sciurba FC; Skeans MA; Voelker H; Walter RE; Wendt CH; Weinmann GG; Wise RA; Foronjy RF
Respir Res; 2009 Nov; 10(1):113. PubMed ID: 19925666
[TBL] [Abstract][Full Text] [Related]
9. The clinical implication of serum cyclophilin A in patients with chronic obstructive pulmonary disease.
Zhang M; Tang J; Yin J; Wang X; Feng X; Yang X; Shan H; Zhang Q; Zhang J; Li Y
Int J Chron Obstruct Pulmon Dis; 2018; 13():357-363. PubMed ID: 29403273
[TBL] [Abstract][Full Text] [Related]
10. Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.
Tufvesson E; Bjermer L; Ekberg M
Int J Chron Obstruct Pulmon Dis; 2015; 10():881-9. PubMed ID: 26005341
[TBL] [Abstract][Full Text] [Related]
11. Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation.
Wu Y; Qin J; He J; Shen Y; Wang H; Li Y; Zeng Q; Dong J; An Y; Xiong S; Feng M; Wen F
Int J Chron Obstruct Pulmon Dis; 2020; 15():397-407. PubMed ID: 32158205
[TBL] [Abstract][Full Text] [Related]
12. Airway inflammation in Japanese COPD patients compared with smoking and nonsmoking controls.
Ishikawa N; Hattori N; Kohno N; Kobayashi A; Hayamizu T; Johnson M
Int J Chron Obstruct Pulmon Dis; 2015; 10():185-92. PubMed ID: 25670894
[TBL] [Abstract][Full Text] [Related]
13. Differences in systemic inflammation between cigarette and biomass smoke-induced COPD.
Golpe R; Martín-Robles I; Sanjuán-López P; Pérez-de-Llano L; González-Juanatey C; López-Campos JL; Arellano-Orden E
Int J Chron Obstruct Pulmon Dis; 2017; 12():2639-2646. PubMed ID: 28979110
[TBL] [Abstract][Full Text] [Related]
14. Altered serum levels of type I collagen turnover indicators accompanied by IL-6 and IL-8 release in stable COPD.
Zeng YY; Hu WP; Zuo YH; Wang XR; Zhang J
Int J Chron Obstruct Pulmon Dis; 2019; 14():163-168. PubMed ID: 30655663
[TBL] [Abstract][Full Text] [Related]
15. Anti-
Banerjee S; Bhattacharyya P; Mitra S; Kundu S; Panda S; Chatterjee IB
Int J Chron Obstruct Pulmon Dis; 2017; 12():1847-1856. PubMed ID: 28684907
[TBL] [Abstract][Full Text] [Related]
16. Change of Serum Inflammatory Cytokines Levels in Patients With Chronic Obstructive Pulmonary Disease, Pneumonia and Lung Cancer.
Chen J; Li X; Huang C; Lin Y; Dai Q
Technol Cancer Res Treat; 2020; 19():1533033820951807. PubMed ID: 33111646
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 and airflow limitation in chemical warfare patients with chronic obstructive pulmonary disease.
Attaran D; Lari SM; Towhidi M; Marallu HG; Ayatollahi H; Khajehdaluee M; Ghanei M; Basiri R
Int J Chron Obstruct Pulmon Dis; 2010 Oct; 5():335-40. PubMed ID: 21037957
[TBL] [Abstract][Full Text] [Related]
18. Circulating syndecan-1 as a novel biomarker relates to lung function, systemic inflammation, and exacerbation in COPD.
Li D; Wu Y; Guo S; Qin J; Feng M; An Y; Zhang J; Li Y; Xiong S; Zhou H; Zeng Q; Chen L; Wen F
Int J Chron Obstruct Pulmon Dis; 2019; 14():1933-1941. PubMed ID: 31695352
[TBL] [Abstract][Full Text] [Related]
19. What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study.
Karrasch S; Brüske I; Smith MP; Thorand B; Huth C; Ladwig KH; Kronenberg F; Heinrich J; Holle R; Peters A; Schulz H
Int J Chron Obstruct Pulmon Dis; 2016; 11():1881-94. PubMed ID: 27574413
[TBL] [Abstract][Full Text] [Related]
20. The value of blood cytokines and chemokines in assessing COPD.
Bradford E; Jacobson S; Varasteh J; Comellas AP; Woodruff P; O'Neal W; DeMeo DL; Li X; Kim V; Cho M; Castaldi PJ; Hersh C; Silverman EK; Crapo JD; Kechris K; Bowler RP
Respir Res; 2017 Oct; 18(1):180. PubMed ID: 29065892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]